AI-powered MarketScan Snapshot speeds real-world data feasibility
The story at a glance:
-
MarketScan Snapshot makes real-world data exploration faster. Teams can use AI-powered, plain-language search to explore patient populations, identify fit-for-purpose data, and assess whether MarketScan data can support their research questions within minutes.
-
Early feasibility checks can happen faster. Snapshot returns relevant patient counts and summary statistics to help teams decide whether deeper MarketScan analysis is warranted.
-
MarketScan combines scale, completeness, and longitudinal depth. The MarketScan® Research Databases include 300M+ cumulative lives, 95M active lives, 99% claims completeness, data access dating back to 1995, and 4.25 years of average patient follow-up.
-
Complimentary access is available for qualified organizations. Current and prospective customers evaluating the MarketScan Research Databases can request MarketScan Snapshot access.
Generating real-world evidence starts with a practical question: does the right data exist to support the analysis? For many life sciences, payer, government, and research teams, answering that question can take days or even weeks of manual data exploration, code review, and feasibility assessment.
MarketScan Snapshot is designed to make that first step faster and more intuitive. The complimentary AI-powered capability helps teams explore the MarketScan Research Databases in everyday language, evaluate patient population counts, and understand whether MarketScan real-world data is fit for their evidence needs.
What is MarketScan Snapshot?
MarketScan Snapshot is an AI-powered way to explore MarketScan Research Databases using plain-language search. Instead of starting with medical codes, database field names, or programming requirements, users can describe the populations, conditions, treatments, or outcomes they want to investigate.
Snapshot then returns relevant patient counts and a summary statistics dashboard, giving teams an early view of cohort size and data availability. That makes it easier to determine whether a deeper MarketScan analysis is worth pursuing before investing additional resources.
Why faster data feasibility matters for real-world evidence
Reliable evidence planning depends on knowing whether a data source can support the question being asked. Before teams can study treatment patterns, outcomes, healthcare utilization, or costs, they need to understand whether the right patient population exists and whether the available data is robust enough for the intended analysis.
By accelerating that early feasibility step, MarketScan Snapshot can help teams align stakeholders faster, prioritize analyses with the strongest evidence potential, and focus specialized analytic support where it can have the greatest impact.
How AI-powered search makes MarketScan data more accessible
MarketScan Snapshot brings AI-powered accessibility to the industry’s most published real-world data asset. Teams no longer need to begin every feasibility question with advanced coding knowledge or specialized database expertise. They can start with the research idea itself, expressed in plain language.
This can be especially valuable during early research planning, when teams are still shaping study questions, comparing possible cohorts, or determining whether a proposed analysis is realistic. Snapshot creates a faster path from idea to feasibility assessment, helping users make better-informed decisions before moving into deeper evidence generation.
Built on the strength of MarketScan real-world data
MarketScan is a longitudinal closed-claims data asset built to support real-world evidence generation across commercial, Medicare, and Medicaid populations. It captures healthcare utilization and actual paid costs across inpatient, outpatient, and pharmacy settings, giving organizations a more complete view of patient journeys and economic outcomes.
That foundation gives Snapshot its value. With access to 300M+ cumulative lives, 95M active lives, 99% claims completeness, data dating back to 1995, and 4.25 years of average patient follow-up, MarketScan Snapshot helps teams explore feasibility against a data environment known for scale, completeness, and longitudinal depth.
Who can use MarketScan Snapshot?
MarketScan Snapshot is designed for teams that need quick clarity on whether MarketScan data can support a potential analysis. That may include life sciences organizations evaluating real-world evidence questions, payer and government teams exploring population-level trends, or academic and health research teams assessing cohort feasibility.
Because Snapshot supports plain-language exploration, it can help a broader set of stakeholders participate earlier in feasibility discussions while still preserving the need for rigorous analytic design and deeper expert review where appropriate.
How to request access to MarketScan Snapshot
Complimentary access to MarketScan Snapshot is available to qualified organizations evaluating the MarketScan Research Databases. Interested teams can request access through the MarketScan Snapshot webpage and will be contacted by a MarketScan team member to confirm eligibility.
Related Articles
MarketScan commercial data shows wide variations in elective surgery prices across U.S.
Key article takeaways
By Manjusha Gokhale | 3 min. read
Navigating QPA compliance under the No Surprises Act
Since the No Surprises Act (NSA) took effect in 2022, health plans have faced a new...
By Kimberly Bouffiou | 2 min. read
Navigate New FDA Guidance on Real-World Evidence with MarketScan
The U.S. Food and Drug Administration (FDA) has formally acknowledged the pivotal...
By Liisa Palmer | 4 min. read
Ready for a consultation?
Our team is ready to answer your questions. Let's make smarter health ecosystems, together.